GLOW 70 MG is a defined three-peptide research blend containing GHK-Cu 50 MG, BPC-157 10 MG, and TB-500 10 MG. Its individual components have been investigated in cellular and preclinical models involving extracellular-matrix remodeling, collagen production, fibroblast activity, cell migration, angiogenesis, inflammatory signaling, and tissue-repair processes.

GHK-Cu is primarily researched for its role in copper-dependent signaling and tissue remodeling. BPC-157 has been investigated for its interaction with angiogenic and repair pathways, while thymosin-beta-4–related research examines actin regulation, cellular migration, and regenerative processes. GLOW provides these three materials in one standardized formulation for investigating their individual and combined characteristics.

Research findings relate primarily to the individual components and preclinical models; they should not be interpreted as established effects of the combined formulation in humans.